Liletta
Device
Medicines360
Total Payments
$10.2M
Transactions
2,927
Doctors
424
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $319,750 | 58 | 8 |
| 2023 | $537,142 | 251 | 186 |
| 2022 | $708,893 | 189 | 41 |
| 2021 | $2.4M | 430 | 50 |
| 2020 | $2.0M | 396 | 25 |
| 2019 | $1.9M | 464 | 77 |
| 2018 | $1.1M | 702 | 94 |
| 2017 | $1.2M | 437 | 25 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.0M | 1,619 | 68.8% |
| Consulting Fee | $3.0M | 685 | 29.4% |
| Royalty or License | $100,000 | 1 | 1.0% |
| Travel and Lodging | $50,266 | 297 | 0.5% |
| Food and Beverage | $12,560 | 296 | 0.1% |
| Education | $6,314 | 9 | 0.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,700 | 6 | 0.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,040 | 6 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,594 | 5 | 0.0% |
| Honoraria | $800.00 | 1 | 0.0% |
| Grant | $750.00 | 1 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $75.00 | 1 | 0.0% |
Payments by Type
Research
$7.0M
1,619 transactions
General
$3.2M
1,308 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase 3 multicenter, open-label study of a Levonorgestrel 52 mg Intrauterine System for the treatment of heavy Menstrual Bleeding | Medicines360 | $4.8M | 0 |
| A Study of a LevonorgestrelReleasing Intrauterine System for LongTerm, Reversible Contraception | Medicines360 | $2.2M | 0 |
Top Doctors Receiving Payments for Liletta — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Gynecology | Phoenix, AZ | $1,500 | 6 |
| , M.D | Specialist | Sacramento, CA | $1,380 | 2 |
| Jill Schwartz | Obstetrics & Gynecology | Arlington, VA | $1,250 | 5 |
| , DO | Obstetrics & Gynecology | Dallas, TX | $1,200 | 2 |
| , MD | Obstetrics & Gynecology | Cleveland, OH | $1,173 | 12 |
| , MD | Gynecology | Rockville, MD | $1,050 | 2 |
| , MD | Obstetrics & Gynecology | Columbus, OH | $939.46 | 9 |
| , M.D | Obstetrics & Gynecology | San Diego, CA | $938.23 | 10 |
| , M.D., M.P.H | Complex Family Planning | Sacramento, CA | $924.24 | 8 |
| , M.D | Gynecology | Atlanta, GA | $894.68 | 5 |
| , M.D., M.P.H | Obstetrics & Gynecology | Portland, OR | $876.37 | 7 |
| , M.D | Student in an Organized Health Care Education/Training Program | Baltimore, MD | $841.78 | 2 |
| , MD, MPH | Obstetrics & Gynecology | Philadelphia, PA | $837.89 | 7 |
| , MD | Obstetrics & Gynecology | Atlanta, GA | $822.90 | 7 |
| , MD | Obstetrics & Gynecology | Atlanta, GA | $810.90 | 7 |
| , M.D | Obstetrics & Gynecology | Las Vegas, NV | $798.91 | 6 |
| , MD | Obstetrics & Gynecology | Pittsburgh, PA | $792.37 | 7 |
| , MD | Reproductive Endocrinology | Dallas, TX | $782.86 | 4 |
| , MD | Obstetrics & Gynecology | Salt Lake City, UT | $758.59 | 8 |
| , MD | Obstetrics & Gynecology | Idaho Falls, ID | $718.90 | 3 |
| , MD | Gynecology | Lawrenceville, NJ | $690.73 | 5 |
| , MD, MAS | Obstetrics & Gynecology | Seattle, WA | $680.00 | 5 |
| , M.D | Obstetrics & Gynecology | New York, NY | $679.35 | 4 |
| , MD | Obstetrics & Gynecology | Houston, TX | $660.50 | 9 |
| , M.D | Obstetrics & Gynecology | Dublin, OH | $660.26 | 3 |
Ad
Manufacturing Companies
- Medicines360 $10.2M
Product Information
- Type Device
- Total Payments $10.2M
- Total Doctors 424
- Transactions 2,927
About Liletta
Liletta is a device associated with $10.2M in payments to 424 healthcare providers, recorded across 2,927 transactions in the CMS Open Payments database. The primary manufacturer is Medicines360.
Payment data is available from 2017 to 2024. In 2024, $319,750 was paid across 58 transactions to 8 doctors.
The most common payment nature for Liletta is "Unspecified" ($7.0M, 68.8% of total).
Liletta is associated with 2 research studies, including "A Phase 3 multicenter, open-label study of a Levonorgestrel 52 mg Intrauterine System for the treatment of heavy Menstrual Bleeding" ($4.8M).